New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2014
11:04 EDTDGXQuest Diagnostics acquisition a strategic positive, says Maxim
Maxim views Quest Diagnostics' acquisition of Solstas Lab Partners as a strategic positive and it recommends buying the stock following the news. The firm reiterates a Buy rating on the stock with a $73 price target.
News For DGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 5, 2015
10:36 EDTDGXQuest Diagnostics management to meet with William Blair
Subscribe for More Information
April 29, 2015
07:21 EDTDGXQuest Diagnostics management to meet with Deutsche Bank
Subscribe for More Information
April 23, 2015
07:08 EDTDGXQuest Diagnostics backs FY15 adjusted EPS view $4.70-$4.85, consensus $4.78
Subscribe for More Information
07:06 EDTDGXQuest Diagnostics reports Q1 adjusted EPS $1.05, consensus $1.04
Subscribe for More Information
April 22, 2015
15:50 EDTDGXNotable companies reporting before tomorrow's open
Subscribe for More Information
April 21, 2015
08:14 EDTDGXQuest Diagnostics and Inserm launch BRCA Share initiative
Quest Diagnostics (DGX) and Inserm, the French National Institute of Health and Medical Research institution, launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. The program's goal is to accelerate research on BRCA gene mutations, particularly variants of uncertain significance, to improve the ability of clinical laboratory diagnostics to predict which individuals are at risk of developing hereditary breast and ovarian cancers. Laboratory Corporation of America Holdings (LH) is the first participant in the initiative, which is structured as a user group. B
06:40 EDTDGXStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use